BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6111580)

  • 1. Short-term in vivo initiation/promotion bioassay for hepatocarcinogens.
    Ford JO; Pereira MA
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):39-46. PubMed ID: 6111580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation/promotion assay for chemical carcinogens in rat liver.
    Herren SL; Pereira MA; Britt AL; Khoury MK
    Toxicol Lett; 1982 Jul; 12(2-3):143-50. PubMed ID: 6126020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
    Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
    Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methapyrilene effects on initiation and promotion of gamma-glutamyl-transpeptidase positive foci in rat liver.
    Couri D; Wilt SR; Milks MM
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):51-61. PubMed ID: 6120543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor promotion in rat liver.
    Herren SL; Pereira MA
    Environ Health Perspect; 1983 Apr; 50():123-9. PubMed ID: 6135606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of rat hepatocytes to phenobarbital after a single dose of N-nitrosodiethylamine in the embryonal and postnatal period or after partial hepatectomy].
    Vinarchuk MP; Kononenko LI; Bykorez AI
    Eksp Onkol; 1987; 9(1):9-11. PubMed ID: 2880709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver.
    Tsuda H; Hasegawa R; Imaida K; Masui T; Moore MA; Ito N
    Gan; 1984 Oct; 75(10):876-83. PubMed ID: 6150874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin.
    Schulte-Hermann R; Ohde G; Schuppler J; Timmermann-Trosiener I
    Cancer Res; 1981 Jun; 41(6):2556-62. PubMed ID: 6165465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of corticoids, adrenalectomy, phenobarbital and pentobarbital in the promotion of DEN-hepatocarcinogenesis.
    Bouzahzah B; Pavier D; Barbason H
    In Vivo; 1998; 12(4):411-9. PubMed ID: 9706493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
    Pitot HC; Goldsworthy T; Moran S; Sirica AE; Weeks J
    Carcinog Compr Surv; 1982; 7():85-98. PubMed ID: 6802499
    [No Abstract]   [Full Text] [Related]  

  • 11. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine.
    Nakae D; Kobayashi Y; Akai H; Andoh N; Satoh H; Ohashi K; Tsutsumi M; Konishi Y
    Cancer Res; 1997 Apr; 57(7):1281-7. PubMed ID: 9102214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between time of partial hepatectomy after a single treatment with diethylnitrosamine and induction of adenosinetriphosphatase-deficient islands in rat liver.
    Ishikawa T; Takayama S; Kitagawa T
    Cancer Res; 1980 Nov; 40(11):4261-4. PubMed ID: 6451284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of markers during hepatocarcinogenesis in rats.
    Lapis K; Ujhelyi E; Gyenes M; Jeney A
    IARC Sci Publ; 1984; (56):25-36. PubMed ID: 6152622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screen of five alkyl carbamates for initiating and promoting activity in rat liver.
    Pereira MA; Khoury MM; Glauert HP; Davis RA
    Cancer Lett; 1991 Apr; 57(1):37-44. PubMed ID: 1673871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay.
    Shibutani M; Takahashi N; Kobayashi T; Uneyama C; Masutomi N; Nishikawa A; Hirose M
    Carcinogenesis; 2002 Jun; 23(6):1047-55. PubMed ID: 12082028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of delays in the cell cycle on the induction of preneoplastic and neoplastic lesions in rat liver by 1,2-dimethylhydrazine.
    Ying TS; Enomoto K; Sarma DS; Farber E
    Cancer Res; 1982 Mar; 42(3):876-80. PubMed ID: 7059985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver.
    Campbell HA; Pitot HC; Potter VR; Laishes BA
    Cancer Res; 1982 Feb; 42(2):465-72. PubMed ID: 6120037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the development of rat liver preneoplastic lesions by verapamil and dexverapamil.
    Ghia M; Mereto E; Cavanna M; Brambilla G
    Anticancer Res; 1996; 16(4A):1739-41. PubMed ID: 8712693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.